Access cutting-edge breast cancer treatment through this clinical trial at a research site in Winston Salem. Study-provided care at no cost to qualified participants.
Access breast cancer specialists in Winston Salem at no cost
This study follows strict safety protocols and ethical guidelines
All study-related breast cancer treatment provided free
The aim of this Phase 1b/2 study is to investigate the safety, efficacy, and pharmacokinetics (PK) of a single dose of LS301-IT, a novel fluorescence imaging agent developed by Integro Theranostics (IT), administered by intravenous (IV) injection in female patients undergoing partial mastectomy for DCIS (whether or not undergoing planned SLNB) or Stage I-II primary invasive breast cancer undergoing SLNB. Safety is the primary objective of this study, followed by efficacy that will be assessed fr
Sponsor: Integro Theranostics
Check if you qualify for this breast cancer clinical trial in Winston Salem, NC
If you're searching for breast cancer treatment options in Winston Salem, NC, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Winston Salem research site is actively enrolling participants for this clinical trial. You'll receive care from experienced breast cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.